Literature DB >> 14660232

Misdiagnosing the vegetative state after severe brain injury: the influence of medication.

Lucy H A Strens1, Gordan Mazibrada, John S Duncan, Richard Greenwood.   

Abstract

Patients who suffer severe brain damage may be left unaware of self and of the environment and in a permanent vegetative state (PVS). The difficulties in correctly ascertaining unawareness after brain injury have been emphasized by a number of authors. It is well recognized that toxic-metabolic and drug-induced cerebral depression occurs acutely after brain injury. However, less attention has been drawn to the effects of medication months after brain injury and the way in which medication may confound assessment of awareness and, thus, the reliable assessment of long-term prognosis. This paper describes two patients who sustained a severe and well-documented structural brain injury, one hypoxic and one traumatic. Both were unaware when first seen at 3 months post-injury, but both have made useful functional recovery. The paper discusses their progress and how the early prescription of large doses of anti-epileptic drugs, sedatives and anti-spastic agents in these circumstances may result in an initial misdiagnosis of the vegetative state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14660232     DOI: 10.1080/0269905031000149533

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  3 in total

1.  Will time heal? A long-term follow-up of severe disorders of consciousness.

Authors:  Inga Steppacher; Michael Kaps; Johanna Kissler
Journal:  Ann Clin Transl Neurol       Date:  2014-05-19       Impact factor: 4.511

Review 2.  Neurotechnological assessment of consciousness disorders: five ethical imperatives.

Authors:  Kathinka Evers
Journal:  Dialogues Clin Neurosci       Date:  2016-06       Impact factor: 5.986

3.  Unexpected emergence from the vegetative state: delayed discovery rather than late recovery of consciousness.

Authors:  Willemijn S van Erp; Anoek M L Aben; Jan C M Lavrijsen; Pieter E Vos; Steven Laureys; Raymond T C M Koopmans
Journal:  J Neurol       Date:  2019-09-20       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.